edasalonexent: Clinical Trials

6 trials of edasalonexent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 4 Phase 1, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 32Completed 1, Terminated 1
Phase 21Completed 1

Follow edasalonexent: new trials by email Literature Review of edasalonexent trials Research Report on edasalonexent

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Edasalonexent With Midazolam and Deflazacort in Healthy Subjects
Edasalonexent 2000 mg TID, Midazolam 2 MG/ML, Deflazacort 36Mg Tab - Healthy
Phase 1CompletedCatabasis Pharmaceuticals262020-08-082021-01-28
An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Edasalonexent - Duchenne Muscular Dystrophy
Phase 3TerminatedCatabasis Pharmaceuticals1302019-03-142020-11-23
Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Edasalonexent, Placebo - Muscular Dystrophy, Duchenne
Phase 3CompletedCatabasis Pharmaceuticals1312018-10-022022-06-21
Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
Edasalonexent, Placebo - Muscular Dystrophy, Duchenne
Phase 1 / Phase 2CompletedCatabasis Pharmaceuticals312016-04-012022-09-23
A Study of CAT-1004 Biomarkers in Healthy Subjects
CAT-1004, Salsalate + DHA, Placebo - Assessment of Mechanistic Blood Biomarkers in Healthy Humans
Phase 1CompletedCatabasis Pharmaceuticals92012-08-012012-10-30
Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers
Drug, Placebo - Healthy
Phase 1CompletedCatabasis Pharmaceuticals522011-09-012012-02-06

Conditions studied

Muscular Dystrophies (3)  ·  Muscular Dystrophy, Duchenne (3)  ·  Musculoskeletal Diseases (3)  ·  Neuromuscular Diseases (3)  ·  Nervous System Diseases (1)

Sponsors

Catabasis Pharmaceuticals (6)

Countries

United States (6)  ·  Australia (2)  ·  Canada (2)  ·  Germany (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Ireland (1)  ·  Israel (1)

Top investigators

Joanne Donovan, MD, PhD (2)  ·  Joanne M Donovan, Chief Medical Officer, MD, PhD (1)  ·  Joanne M Donovan, MD, PhD (1)  ·  Scott Rasmussen, MD (1)

Results publications

PMID 34120912